XNAS · ALVO

-3.82% · -$0.1550 · Vol 591.7K

Market closed · last close 4:00 PM ET · price as of 16:22:20 ET

Alvotech Ordinary Shares

$3.90

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET · ALVO

Methodology

ALVO

Alvotech Ordinary Shares

Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET

50/100

NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

50/ 100

Veridion Score

NEUTRAL · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is ALVO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move ALVO next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Earnings / Congress / Score

Upcoming

Aug 19
Earnings
Earnings report scheduled
EPS est -0.03
Earnings calendarSource

Recent

Aug 17
Score
Score moved -5
55/NEUTRAL -> 50/NEUTRAL
Veridion score historySource
Oct 5
CongressChecking access
Byron Donalds sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 5
CongressChecking access
Byron Donalds exchange disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 2
CongressChecking access
Byron Donalds exchange disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Alvotech Ordinary Shares

Listed since

2022

Employees

Country

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$4.04

Day high

$4.04

Day low

$3.77

Previous close

$4.05

52W high